Faculty scientist recognised for entrepreneurial spirit

curtisdobsonDr Curtis Dobson has won the Commercial Innovator of the Year award at the BBSRC’s Fostering Innovation Awards 2014. The awards were presented in London, in front of a prestigious audience featuring leading figures from the worlds of investment, industry, government, charity, and academia. He scooped the £15,000 award in recognition of two successful healthcare companies that are based on his research.

Ai2 Ltd has developed anti-infective peptide technology for use in ophthalmics and medical devices. This technology helps to reduce infections caused by contact lenses, catheters, wound dressings, and orthopaedic devices. Microsensor Ltd is developing a new approach to the early detection of medical device infection and environmental monitoring. The technology is simple, inexpensive, and robust, proving a clear indication of clinically or industrially relevant levels of infection on a surface. Dr Curtis Dobson said:

“Being recognised by this BBSRC award is a privilege and an honour, and further validates our efforts to tackle resistant infection, which impacts so many people throughout the UK and beyond. The additional funds will help us accelerate commercialisation of our latest technologies, ultimately delivering benefits to patients sooner.”

Professor Ian Kimber, Faculty Associate Dean for Business Development, said:

“This is a remarkable achievement and is a testament to the industry and innovation of Curtis and his co-workers. It is a reflection also of the emphasis we place on ensuring that the fruits of our substantial investment in research deliver valuable products and opportunities.”

Faculty researcher among BBSRC Innovator of the Year finalists 2014

A Faculty researcher is among nine shortlisted finalists for the 2014 BBSRC (Biotechnology and Biological Sciences Research innovatorCouncil) Innovator of the Year competition who were announced today.

Curtis Dobson has been shortlisted in the Commercial Innovator section for his serial innovations focusing on the treatment or detection of infectious agents on medical device surfaces.

He joins Neil Gibbs and Catherine O’Neill, from the Faculty of Medical and Human Science’s Institute of Inflammation and Repair, who have been shortlisted in the same category for their novel approaches to safe skin healthcare – Curapel.

The innovators will be competing to be crowned Innovator of the Year 2014 at a high-profile event in London on 20 March 2014 in recognition of their efforts to take their innovation beyond the lab to deliver social and economic benefits.

The other categories include Social Innovator and Most Promising Innovator reflecting the breadth of the benefits delivered by BBSRC’s investment in UK bioscience. One of the category winners will then be chosen as the overall Innovator of the Year.

Winners in each category will receive a £15,000 award for them to support their research, training or other activities promoting economic or social impact. The overall winner will receive a further £15,000.

The finalists will be judged by an expert independent panel. The judges will be looking to recognise those innovators who have worked the hardest and gone the furthest to take their science out of the lab to deliver impact.

Innovator of the Year is one of BBSRC’s Fostering Innovation competitions that aim to promote excellence amongst researchers, knowledge exchange practitioners, departments and institutions by recognising successful approaches to innovation and impact in the biosciences.

More information about Innovator of the Year can be found on the BBSRC website.